CLAIRE ROGERS: Open Payments
NPI 1275716938 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,691 in 142 payments from 18 companies in 2025. Trend: 2023 $7,391 · 2024 $3,690 · 2025 $2,691
Food & beverage: $2,534Education: $157
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $374 |
| Novartis Pharmaceuticals Corporation | 20 | $350 |
| Janssen Biotech, Inc. | 20 | $270 |
| ABBVIE INC. | 12 | $202 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $200 |
| LEO Pharma Inc. | 13 | $189 |
| Arcutis Biotherapeutics, Inc. | 9 | $153 |
| Organon LLC | 4 | $147 |
| Lilly USA, LLC | 5 | $141 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $135 |
Products named: DUPIXENT, TREMFYA, COSENTYX, Zoryve, SKYRIZI, EBGLYSS, ADBRY, CIBINQO.
Industry payments across GA — which companies pay providers there.
